Insider filing · NTRA
Roelof Botha
Director
profile →
Natera, Inc.
NTRA · Healthcare · 219 filings in 24 months
ticker →
Roelof Botha sold $17.2M of Natera (NTRA)
Executed Jun 1, disclosed Jun 3, 2 days later.
Value, as filed
$17.2M
78,000 sh across 6 lots
Executed
Jun 1
the trade date, as filed
Disclosed
Jun 3
2 days after the trade
Return, 21 sessionsiFrom the disclosed entry session; derived
–
purchases only
Returns are measured on stock purchases only.
The filer
RBRoelof Botha (Director) filed 5 Form 4 reports in the trailing twelve months (1 purchase, 4 sales), most often in Natera, Inc. (NTRA). Across 1 priced purchase filing, the average 21-session return was -35.0% from execution and -15.9% from disclosure (delay-adjusted; derived). The largest single filing was $17.7M of NTRA (75,000 sh across 11 lots, as filed), executed Nov 24 2025.
The name
NTRAHealthcare · Natera, Inc., a diagnostics company, engages in the development and commercialization of molecular testing services worldwide
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→Other filings by Roelof Botha in NTRA
NTRASALE
Natera, Inc.
$17.7M75,000 sh across 11 lots
Exec Nov 24 2025
Filed Nov 26 2025 · 5:30 PM ET NTRASALE Natera, Inc. $14.8M
87,473 sh across 5 lots
Exec Dec 2 2024
Filed Dec 4 2024 · 5:30 PM ET